Nakamura Shotaro | Secomedic Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
PJ-296 Percutaneous Coronary Intervention for Acute Myocardial Infarction in the Elderly : Comparison on Clinical Outcome between Younger Patients, Septuagenarians and Octogenarians(Acute myocardial infarction, clinical (diagnosis/treatment)-8 (IHD) PJ50,
OJ-392 Durability of Endoluminal Stenting for Obstructive Lesions of the Subclavian Artery : Multicenter Registry in Japan(Peripheral circulation-2 (H) OJ66,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circul
OJ-141 Coronary Artery Perforations : Incidence, Predictors and Clinical Outcomes : Multicenter Registry in Japan(Coronary revascularization, PCI-6 (IHD) OJ24,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circ
Comparison of Efficacy Between Sirolimus-Eluting Stent (Cypher^) and Paclitaxel-Eluting Stent (TAXUS^) in Unprotected Left Main Coronary Arteries (Angina Pectoris, Basic/Clinical 4 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulat
One-Year Clinical Outcome of Cypher Sirolimus-Eluting Stents in Patients with Long Coronary Lesions : Multicenter Registry in Asia (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of the Japanes
Comparison of Efficacy Between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Chronic Total Occlusions (Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD), The 69th Annual Scientific Meeting of t
Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Unprotected Left Main Coronary Arteries 2-Year Results(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scienti
4 Comparison of Efficacy and Durability between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Plenary Session 1 (PL-1) (IHD) Drug-Eluting Stents : Long-Term Effects and Emerging Problems,Special Program,Th
PJ-771 Diabetic Patients Requiring Insulin Therapy Have Worse Clinical Outcome after Drug-Eluting Stent Implantation : Multicenter Registry in Asia(Diabetes/Obesity/Metabolic syndrome-11, The 71st Annual Scientific Meeting of the Japanese Circulation Soci
PJ-753 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Coronary revascularization, PCI-22, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-732 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-728 Drug-Eluting Stents for the Treatment of Chronic Total Occlusion : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-18, The 71st Annual Scientific Meeting of the Japanese Circulation
PJ-603 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Cir
PJ-602 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Patients with Diffuse In-Stent Restenosis(Coronary revascularization, PCI-16, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-596 Drug-Eluting Stents for the Treatment of Very Long Coronary Artery Stenosis : A Comparison with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese C
PJ-595 Drug-Eluting Stent for the Treatment of Small Coronary Artery with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-15, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-594 Drug-Eluting Stents for the Treatment of Left Main Coronary Arteries with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-590 Impact of Sirolimus-Eluting Stents on the One-Year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
FRS-008 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment in Patients with Unprotected Left Main Arteries : Multicenter Registry in Asia 4-Year Results(Coronary Revascularization (clinical) 1, The 71st Annual Scientific Meeting of the
2 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-Eluting Stent(Strategies for Treatment of Left Main Trunk Disease, The 71st Annual Scientific Meeting of the Japanese Circu
FRS-119 The Effect of Drug-Eluting Stents on Clinical and Angiographic Outcomes in Diabetic Patients : Multicenter Registry in Asia(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-420 Durable Clinical Benefit Following Paclitaxel-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 2-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anni
OJ-158 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese),The 70th Anniversary Annual Scien
PJ-010 Three-Year Follow-Up Patients with ST Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent : Multicenter Registry in Asia(Acute myocardial infarction, clinical (diagnosis/treatment)-5, The
PJ-419 Durable Clinical Benefit Following Sirolimus-eluting Stent Deployment on the Outcome of Patients with Diffuse In-stent Restenosis : Multicenter Registry 3-year Results(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniv
PJ-354 Durable Clinical Benefit Following Sirolimus-eiuting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-registry 3-year Results(Coronary revascularization, PCI-15 (IHD) PJ60,Poster Session (Japanese),The 70t
OJ-234 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Mee
OJ-233 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Diffuse In-Stent Restenosis(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary Ann
OJ-161 Durable Clinical Benefit Following Sirolimus-Eluting Stent Deployment on the Outcome of Patients with Chronic Total Occlusions : Multicenter Registry 3-Year Results(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese)
OJ-098 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-Year Results(Coronary revascularization, PCI-5 (IHD) OJ17,Oral Presentation (Japanese),The 70th Annivers
FRS-006 Long-Term Follow-Up Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent(Strategies to Acute Myocardial Infarction-2 (IHD) FRS2,Featured Research Session,The 70th Annivers
FRS-083 Durable Clinical Benefit Following Sirolimus-eluting Stent on the Outcome of Patients with Very Long Coronary Lesions : Multicenter Registry 2-year Results(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scien
FRS-081 Impact of Sirolimus-eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(New PCI-2 (IHD) FRS17,Featured Research Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese
PJ-512 Comparison of Efficacy between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Chronic Total Occlusions(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniversary Annua
OJ-030 Impact of Sirolimus-Eluting Stents on the Outcome of Patients with Diffuse In-Stent Restenosis : Multicenter Registry in Asia(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the
OJ-009 Impact of Paclitaxel-Eluting Stents on the One-year Outcome of Patients with Bifurcation Lesions : Multicenter Registry in Asia(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting
OJ-008 Comparison of Efficacy and Safety between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 70th Anniversary Annual Scientifi
OJ-007 Durable Clinical Benefit Following Paclitaxel-Eluting Stent on the Outcome of Patients with Unprotected Left Main Coronary Arteries : Multicenter-Registry 2-year Results(Coronary revascularization, PCI-4 (IHD) OJ2,Oral Presentation (Japanese),The 7
FRS-109 Comparison of Efficacy and Safety Between Sirolimus-eluting Stent and Paclitaxel-eluting Stent in Patients with Diabetes Mellitus : Multicenter-registry in Asia(Progress in Preventive Medicine-2 (H) FRS22,Featured Research Session (English),The 70
PJ-508 Comparison of Efficacy and Safety between Sirolimus-eluting Stent and Paclitaxel-eluting Stent on the Outcome of Patients with Small Coronary Arteries(Chronic coronary heart disease/Remodeling-4 (IHD) PJ86,Poster Session (Japanese),The 70th Anniver

もっと見る

スポンサーリンク